March 1, 2011 - Recently Published Faculty
Dr. Hanley & Waldenstrom’s Macroglobulinemia
Dr. Hanley in Torch: the International Waldenstrom’s Macroglobulinemia Foundation Newsletter
One of Dr. Hanley’s many areas of expertise was recently highlighted in an article in Torch: the International Waldenstrom’s Macroglobulinemia Foundation Newsletter. The Torch described Dr. Hanley as “a living legend to the readers” and re-emphasized her warning to “be sure to get a dilated eye exam” at a patient’s mention of an elevated level of serum viscosity. The article, entitled “Waldenstrom and the Eye,” goes on to discuss the effects of Waldenstrom’s Macroglobulinemia on different parts of the eye and what patients can do to protect their vision in the upcoming year.
For more information on Waldenstrom’s Macroglobulinemia, visit http://www.iwmf.com/.
Dr. Jane Gwiazda and COMET2
COMET2 results published in IOVS and presented at the American Academy of Optometry annual meeting by Dr. Jane Gwiazda
The COMET2 study, chaired by Dr. Jane Gwiazda and conducted with the Pediatric Eye Disease Investigator Group, was designed to follow up on a promising result from the original COMET. COMET2 investigated whether progressive addition lenses (PALs), relative to single vision lenses (SVLs), slowed the progression of low myopia in children with high accommodative lag and near esophoria. The main result was a 3-year treatment benefit of 0.28D in the PAL group. We concluded that the PALs (Essilor Ellipse) had a statistically but not clinically significant effect on slowing myopia progression in these children. The results were recently published in Invest. Ophthalmol. Vis. Sci. (31 January 2011, 10.1167/iovs.10-6631).
The President of the American Academy of Optometry, Karla S. Zadnik, OD, PhD, also highlighted the presentation of the COMET2 results in her December report to Academy members:
“By now, you've all heard about the record-breaking Annual Meeting figures from San Francisco: 212 new Fellows, more than 5,800 registrants, 48,079 hours of continuing education credit, and rumor that it was the biggest single optometric meeting ever staged. What those numbers don't tell you, however, is about the little spine-tingling moments that occurred throughout the meeting. Here's what I heard and observed.
A large room was packed with scientists and clinicians (identifiable because they were laughing at Tom Norton's oldest jokes) as they hung on Jane Gwiazda's every word during her first public presentation of the COMET 2 results. The heroic work, completed through the auspices of the ophthalmology-optometry joint venture, the Pediatric Eye Disease Investigators Group, showed a modest (0.25 D) difference in myopia progression in low myopes with high accommodative lag and near esophoria when corrected with progressive addition lenses.”
Visit the NECO library for this and other articles on Dr. Gwiazda and COMET.
Return to main News page